The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

OBJECTIVES: This systematic review aimed to assess the role of magnetic resonance imaging (MRI) in evaluating residual disease extent and the ability to detect pathologic complete response (pCR) after neoadjuvant chemotherapy for invasive breast cancer. METHODS: PubMed, the Cochrane Library, MEDLINE...

Descripción completa

Detalles Bibliográficos
Autores principales: Lobbes, M. B. I., Prevos, R., Smidt, M., Tjan-Heijnen, V. C. G., van Goethem, M., Schipper, R., Beets-Tan, R. G., Wildberger, J. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609956/
https://www.ncbi.nlm.nih.gov/pubmed/23359240
http://dx.doi.org/10.1007/s13244-013-0219-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609956/
https://www.ncbi.nlm.nih.gov/pubmed/23359240
http://dx.doi.org/10.1007/s13244-013-0219-y

Ejemplares similares